HANDBOOK OF TARGETED CANCER THERAPY AND IMMUNOTHERAPY : GASTROINTESTINAL CANCER

Comprehensive yet concise, this easy-access resource by Dr. Milind Javle of MD Anderson Cancer Center and Dr. Mitesh J. Board of Mayo Clinic helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of investigational targeted agents and combinations of agents.

What is the content of "Handbook of Targeted Cancer Therapy and Immunotherapy"?

• Covers gastrointestinal cancer targets—stage 1, 2, and 3 trials and preliminary results, as well as approved therapies. 
• Includes sections on Sequencing Technologies, and Targeted and Immunotherapy Agents.  
• Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction. 
• Highlights FDA approvals throughout. 
• Pocket-sized and color coded to help you find information quickly and easily. 

Enrich Your eBook Reading Experience 

• Read directly on your preferred device(s), such as computer, tablet, or smartphone. 
• Easily convert to audiobook, powering your content with natural language text-to-speech. 

Who is the author of "Handbook of Targeted Cancer Therapy and Immunotherapy"?

Milind Javle, M.D., Professor, GI Medical Oncology, Graduate School of Biomedical Sciences, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine. MD Anderson Cancer Center, Houston, TX, USA